Hamilton Bennett | Sr. Director Vaccine Access and Partnerships
Moderna

Hamilton Bennett, Sr. Director Vaccine Access and Partnerships, Moderna

Hamilton Bennett (she/her) is the Senior Director of Vaccine Access and Partnerships at Moderna, a company pioneering messenger RNA (mRNA) therapeutics and vaccines. In this role, Hamilton is responsible for the Global Public Health and Medical Countermeasures portfolio, driving collaborative research and development with a broad range of government and academic collaborators, which has allowed for the pursuit of groundbreaking science to drive public health. Hamilton led the mRNA-1273 COVID-19 vaccine development Program Team to the authorized use and approval of one of the earliest and most effective vaccines against the COVID-19 pandemic. Most recently, Hamilton launched mRNA Access to provide researchers access to Moderna’s early development engine to collaboratively advance novel vaccines targeting emerging and neglected infectious disease. Prior to Moderna, Hamilton led small molecule and monoclonal antibody pandemic preparedness programs at boston biopharma companies.

Appearances:



Pre-Congress Workshops - Monday 28th October @ 10:00

Platform Technologies Workshop [AM1]

Session led by: etherna
Session led by: adaptvac
Session led by: quantoom-biosciences
Session led by: pfizer

Day 3 - Thursday 31st October @ 09:30

Partnerships & Access Track Chair

Day 3 - Thursday 31st October @ 12:30

Partnerships & Access Track Chair

last published: 03/Oct/24 13:35 GMT

back to speakers